FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1969448066> ?p ?o ?g. }

• W1969448066 endingPage "83" @default.
• W1969448066 startingPage "72" @default.
• W1969448066 abstract "Basic fibroblast growth factor (FGF-2) and its respective tyrosine kinase receptors, form an autocrine loop that affects human melanoma growth and metastasis. The aim of the present study was to examine the possible participation of various glycosaminoglycans, i.e. chondroitin sulfate, dermatan sulfate and heparin on basal and FGF-2-induced growth of WM9 and M5 human metastatic melanoma cells. Exogenous glycosaminoglycans mildly inhibited WM9 cell's proliferation, which was abolished by FGF-2. Treatment with the specific inhibitor of the glycosaminoglycan sulfation, sodium chlorate, demonstrated that endogenous glycosaminoglycan/proteoglycan production is required for both basal and stimulated by FGF-2 proliferation of these cells. Heparin capably restored their growth, and unexpectedly exogenous chondroitin sulfate to WM9 and both chondroitin sulfate and dermatan sulfate to M5 cells allowed FGF-2 mitogenic stimulation. Furthermore, in WM9 cells the degradation of membrane-bound chondroitin/dermatan sulfate stimulates basal growth and even enhances FGF-2 stimulation. The specific tyrosine kinase inhibitor, genistein completely blocked the effects of FGF-2 and glycosaminoglycans on melanoma proliferation whereas the use of the neutralizing antibody for FGF-2 showed that the mitogenic effect of chondroitin sulfate involves the interaction of FGF-2 with its receptors. Both the amounts of chondroitin/dermatan/heparan sulfate and their sulfation levels differed between the cell lines and were distinctly modulated by FGF-2. In this study, we show that chondroitin/dermatan sulfate-containing proteoglycans, likely in cooperation with heparan sulfate, participate in metastatic melanoma cell FGF-2-induced mitogenic response, which represents a novel finding and establishes the central role of sulfated glycosaminoglycans on melanoma growth." @default.
• W1969448066 created "2016-06-24" @default.
• W1969448066 creator A5012410418 @default.
• W1969448066 creator A5028729044 @default.
• W1969448066 creator A5044109342 @default.
• W1969448066 creator A5044155540 @default.
• W1969448066 creator A5059126346 @default.
• W1969448066 creator A5071513503 @default.
• W1969448066 creator A5078469311 @default.
• W1969448066 date "2008-01-01" @default.
• W1969448066 modified "2023-09-25" @default.
• W1969448066 title "Chondroitin sulfate and heparan sulfate-containing proteoglycans are both partners and targets of basic fibroblast growth factor-mediated proliferation in human metastatic melanoma cell lines" @default.
• W1969448066 cites W1656644300 @default.
• W1969448066 cites W1686153396 @default.
• W1969448066 cites W1807684861 @default.
• W1969448066 cites W1930119421 @default.
• W1969448066 cites W1969396800 @default.
• W1969448066 cites W1971939181 @default.
• W1969448066 cites W1972624690 @default.
• W1969448066 cites W1974873948 @default.
• W1969448066 cites W1976740882 @default.
• W1969448066 cites W1981180318 @default.
• W1969448066 cites W1985737377 @default.
• W1969448066 cites W1987556027 @default.
• W1969448066 cites W2001496130 @default.
• W1969448066 cites W2003632139 @default.
• W1969448066 cites W2006188134 @default.
• W1969448066 cites W2006641366 @default.
• W1969448066 cites W2016883388 @default.
• W1969448066 cites W2037371382 @default.
• W1969448066 cites W2048781363 @default.
• W1969448066 cites W2053006673 @default.
• W1969448066 cites W2053425459 @default.
• W1969448066 cites W2056174123 @default.
• W1969448066 cites W2056983875 @default.
• W1969448066 cites W2061348601 @default.
• W1969448066 cites W2065371374 @default.
• W1969448066 cites W2066438491 @default.
• W1969448066 cites W2073627121 @default.
• W1969448066 cites W2075500765 @default.
• W1969448066 cites W2080432157 @default.
• W1969448066 cites W2088703066 @default.
• W1969448066 cites W2089382319 @default.
• W1969448066 cites W2089923335 @default.
• W1969448066 cites W2116715149 @default.
• W1969448066 cites W2142355688 @default.
• W1969448066 cites W2170862003 @default.
• W1969448066 cites W2184162979 @default.
• W1969448066 cites W2261262361 @default.
• W1969448066 cites W2466914879 @default.
• W1969448066 cites W618558318 @default.
• W1969448066 cites W635381471 @default.
• W1969448066 doi "https://doi.org/10.1016/j.biocel.2007.06.019" @default.
• W1969448066 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17706452" @default.
• W1969448066 hasPublicationYear "2008" @default.
• W1969448066 type Work @default.
• W1969448066 sameAs 1969448066 @default.
• W1969448066 citedByCount "50" @default.
• W1969448066 countsByYear W19694480662012 @default.
• W1969448066 countsByYear W19694480662013 @default.
• W1969448066 countsByYear W19694480662014 @default.
• W1969448066 countsByYear W19694480662015 @default.
• W1969448066 countsByYear W19694480662016 @default.
• W1969448066 countsByYear W19694480662017 @default.
• W1969448066 countsByYear W19694480662018 @default.
• W1969448066 countsByYear W19694480662019 @default.
• W1969448066 countsByYear W19694480662020 @default.
• W1969448066 countsByYear W19694480662021 @default.
• W1969448066 countsByYear W19694480662022 @default.
• W1969448066 countsByYear W19694480662023 @default.
• W1969448066 crossrefType "journal-article" @default.
• W1969448066 hasAuthorship W1969448066A5012410418 @default.
• W1969448066 hasAuthorship W1969448066A5028729044 @default.
• W1969448066 hasAuthorship W1969448066A5044109342 @default.
• W1969448066 hasAuthorship W1969448066A5044155540 @default.
• W1969448066 hasAuthorship W1969448066A5059126346 @default.
• W1969448066 hasAuthorship W1969448066A5071513503 @default.
• W1969448066 hasAuthorship W1969448066A5078469311 @default.
• W1969448066 hasConcept C153074725 @default.
• W1969448066 hasConcept C153911025 @default.
• W1969448066 hasConcept C170493617 @default.
• W1969448066 hasConcept C185592680 @default.
• W1969448066 hasConcept C22731427 @default.
• W1969448066 hasConcept C2776735749 @default.
• W1969448066 hasConcept C2778041096 @default.
• W1969448066 hasConcept C2778066728 @default.
• W1969448066 hasConcept C2779553658 @default.
• W1969448066 hasConcept C55493867 @default.
• W1969448066 hasConcept C74373430 @default.
• W1969448066 hasConcept C86803240 @default.
• W1969448066 hasConcept C95444343 @default.
• W1969448066 hasConceptScore W1969448066C153074725 @default.
• W1969448066 hasConceptScore W1969448066C153911025 @default.
• W1969448066 hasConceptScore W1969448066C170493617 @default.
• W1969448066 hasConceptScore W1969448066C185592680 @default.
• W1969448066 hasConceptScore W1969448066C22731427 @default.
• W1969448066 hasConceptScore W1969448066C2776735749 @default.
• W1969448066 hasConceptScore W1969448066C2778041096 @default.

• next